Correlation Between Bumrungrad Hospital and China BlueChemical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bumrungrad Hospital and China BlueChemical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bumrungrad Hospital and China BlueChemical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bumrungrad Hospital Public and China BlueChemical, you can compare the effects of market volatilities on Bumrungrad Hospital and China BlueChemical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bumrungrad Hospital with a short position of China BlueChemical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bumrungrad Hospital and China BlueChemical.

Diversification Opportunities for Bumrungrad Hospital and China BlueChemical

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Bumrungrad and China is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Bumrungrad Hospital Public and China BlueChemical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China BlueChemical and Bumrungrad Hospital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bumrungrad Hospital Public are associated (or correlated) with China BlueChemical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China BlueChemical has no effect on the direction of Bumrungrad Hospital i.e., Bumrungrad Hospital and China BlueChemical go up and down completely randomly.

Pair Corralation between Bumrungrad Hospital and China BlueChemical

Assuming the 90 days trading horizon Bumrungrad Hospital Public is expected to under-perform the China BlueChemical. But the stock apears to be less risky and, when comparing its historical volatility, Bumrungrad Hospital Public is 1.12 times less risky than China BlueChemical. The stock trades about -0.33 of its potential returns per unit of risk. The China BlueChemical is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  23.00  in China BlueChemical on September 2, 2024 and sell it today you would earn a total of  1.00  from holding China BlueChemical or generate 4.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bumrungrad Hospital Public  vs.  China BlueChemical

 Performance 
       Timeline  
Bumrungrad Hospital 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bumrungrad Hospital Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
China BlueChemical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in China BlueChemical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, China BlueChemical reported solid returns over the last few months and may actually be approaching a breakup point.

Bumrungrad Hospital and China BlueChemical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bumrungrad Hospital and China BlueChemical

The main advantage of trading using opposite Bumrungrad Hospital and China BlueChemical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bumrungrad Hospital position performs unexpectedly, China BlueChemical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China BlueChemical will offset losses from the drop in China BlueChemical's long position.
The idea behind Bumrungrad Hospital Public and China BlueChemical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance